Clinical trial
Strict IGF-1 Control in Acromegaly (I-Con Study)
NCT02952885 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Strict IGF-1 Control in Acromegaly (I-Con Study)
- Lead sponsor
- Unity Health Toronto
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 27, 2017
- Completion date
- May 7, 2020
- Enrollment
- 10 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.